Amantadine: A Review of Use in Child and Adolescent Psychiatry
Year: 2013
Type: article
Abstract: OBJECTIVE: To review published literature regarding the pharmacology and use of amantadine in child and adolescent psychiatry. METHOD: A literature search of several databases (PubMed, Psychinfo, CINAHL, Medline, PsycARTICLES, Biomedical Reference Collection and Academis Search Complete) was conducted with the search terms: ‘amantadine’ with limits: English language, Human trials, all child (aged 0–18 years). The search was later expanded to include ‘Adults’ and additional relevant articles were selected from reference lists. RESULTS: The psychotropic effect of amantadine is related to its antagonism of the N-methyl-D-aspartate (NMDA) receptor. It decreases the toxic effects of the glutamatergic neurotransmitter system which plays an important role in many psychiatric disorders. Two randomized controlled trials (RCTs) of amantadine were identified in children and adolescents. One reported beneficial effects in controlling the symptoms of irritability and hyperactivity in autistic disorder and the other described a significant impact in attention deficit hyperactivity disorder (ADHD). Two open label studies also reported positive effects in ADHD. A pilot study in children with enuresis reported significant reduction in wetting frequency. Studies in adults, with relevance to children and adolescents, reported effectiveness in resistant depression, obsessive compulsive disorder and in counteracting side effects of some psychotropic medications. RCTs found in traumatic brain injury indicated a neuroprotective effect and effectiveness in controlling agitation and aggression. Amantadine is well tolerated in children and adolescents, with an acceptable side effect profile, and considered safe for long term use. CONCLUSION: Amantadine shows potential for use as a safe alternative or as an augmenting agent for treating children with neuropsychiatric and various other disorders. Available data for such use, although promising, require further confirmation.
Source: Europe PMC (PubMed Central)
Authors: Hosenbocus, Sheik, Chahal, Raj
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: amantadine, NMDA receptor antagonism, glutamatergic system, autism spectrum disorder, attention deficit hyperactivity disorder, irritability, enuresis, treatment-resistant depression, obsessive-compulsive disorder, traumatic brain injury, neuroprotection, agitation and aggression, child psychiatry, drug safety and tolerability
Open Access status: green
OpenAlex ID: W7073830660
